Monsanto’s Cancer Cover-Up: ‘Decades of deceptive Tactics To Make Billions Of Dollars’

6 February 2018

 - Monsanto has been using different tactics to suppress vital information for people who are being exposed to Roundup to decide if they want to use it or not, says Carey Gillam, investigative journalist and author.

The story with the agricultural giant’s Roundup weed killer began in the 1980s when tests on its primary ingredient, glyphosate, began to show cellular changes in laboratory animals that should have been considered early signals that the product could cause cancer. In 1995, the US Environmental Protection Agency (EPA) determined that this compound needed to be classified as a carcinogen.

However, six years later the EPA changed that classification and said it was wrong to designate it as a possible carcinogen, adding that the public had nothing to worry about.

Moreover, the laboratory data from the 1980s that the EPA used to classify glyphosate as carcinogenic suddenly became unavailable to the public, as Monsanto argued that all the early testing results for this chemical fell under the protection of the trade secret rule.